Global R&D Heads Talk Superbugs, PROTACs And More

Risk Is Essential To Discovery

A panel of R&D experts from Merck’s EMD Serono, Boehringer Ingelheim, Takeda and Hilleman Labs discuss technologies like PROTACs and multi-specific antibodies, a superbug that could cause more damage than COVID-19 and the need for harmonized regulation that recognizes risk is essential to discovery

Conceptual representation of a superbug
Is The Next Superbug On The Horizon? • Source: Alamy

The world is still not over COVID-19 yet and the next threat leading to many more millions of body bags could be around the corner.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from R&D

More from Scrip